This hottest twist from the Lykos Therapeutics saga threatens An important overhaul of the company’s tactic and course, with Musk ally and billionaire Trader Antonio Gracias showing to desire to just take the corporate again towards its nonprofit drug development roots and a more Doblinite philosophy.“I put in the weekend speaking lots about th